COM:VINCERX
Vincerx Pharma, Inc.
- Stock
Last Close
0.26
22/11 21:00
Market Cap
19.29M
Beta: -
Volume Today
228.99K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | -619K - | -619K 0% | ||||
average payables | 263K - | 1.25M 377.19% | 2.54M 102.55% | 2.78M 9.40% | ||
average receivables | 686K - | 1.21M 76.09% | ||||
book value per share | 10.98 - | 5.84 46.82% | 2.27 61.19% | 0.53 76.75% | ||
capex per share | -0.31 - | |||||
capex to depreciation | -15.46 - | |||||
capex to operating cash flow | 0.16 - | |||||
capex to revenue | ||||||
cash per share | 11.77 - | 6.49 44.84% | 2.49 61.56% | 0.60 75.80% | ||
days of inventory on hand | ||||||
days payables outstanding | 1.04K - | 996.07 - | ||||
days sales outstanding | ||||||
debt to assets | 0.04 - | 0.06 63.39% | 0.14 136.98% | |||
debt to equity | 0.04 - | 0.07 73.25% | 0.22 209.31% | |||
dividend yield | ||||||
earnings yield | -0.10 - | -0.09 8.73% | -2.66 2,888.29% | -1.60 40.03% | ||
enterprise value | 48.03M - | 67.74M 41.04% | 13.22M 80.48% | 14.78M 11.75% | ||
enterprise value over ebitda | -4.48 - | -0.79 82.43% | -0.18 77.60% | -0.35 100.85% | ||
ev to operating cash flow | -21.07 - | -2.03 90.38% | -0.22 89.06% | -0.37 64.65% | ||
ev to sales | ||||||
free cash flow per share | -0.43 - | -2.25 418.70% | -2.83 25.93% | -1.90 32.98% | ||
free cash flow yield | -0.02 - | -0.22 964.39% | -2.78 1,158.03% | -1.61 42.07% | ||
graham net net | 10.72 - | 5.48 48.88% | 1.96 64.20% | 0.31 84.10% | ||
graham number | 22.47 - | 10.93 51.37% | 11.77 7.74% | 4.73 59.84% | ||
income quality | 0.21 - | 0.85 299.80% | 0.91 7.30% | 1.01 10.48% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | -1.34K - | 8.96 - | ||||
interest debt per share | 0.00 - | 0.24 15,853.84% | -0.23 193.36% | 0.12 151.79% | ||
inventory turnover | ||||||
invested capital | 0.04 - | 0.07 73.25% | 0.22 209.31% | |||
market cap | 109.82M - | 175.02M 59.37% | 21.45M 87.74% | 25.13M 17.15% | ||
net current asset value | -44K - | 57.60M 131,020.45% | 94.49M 64.02% | 44.35M 53.07% | 7.74M 82.55% | |
net debt to ebitda | 5.77 - | 1.25 78.37% | 0.11 91.20% | 0.25 126.16% | ||
net income per share | -2.04 - | -0.91 55.52% | -2.72 199.12% | -1.89 30.62% | ||
operating cash flow per share | -0.43 - | -1.94 348.16% | -2.83 45.75% | -1.90 32.98% | ||
payables turnover | 0.35 - | 0.37 - | ||||
receivables turnover | ||||||
research and ddevelopement to revenue | ||||||
return on tangible assets | -0.17 - | -0.13 21.89% | -0.96 626.91% | -2.20 128.64% | ||
revenue per share | ||||||
roe | -0.19 - | -0.16 16.36% | -1.20 670.74% | -3.58 198.42% | ||
roic | -0.19 - | -0.23 23.18% | -1.18 415.23% | -2.83 139.78% | ||
sales general and administrative to revenue | ||||||
shareholders equity per share | 10.98 - | 5.84 46.82% | 2.27 61.19% | 0.53 76.75% | ||
stock based compensation to revenue | ||||||
tangible asset value | -44K - | 57.69M 131,206.82% | 100.32M 73.91% | 47.67M 52.48% | 11.22M 76.46% | |
tangible book value per share | 10.98 - | 5.84 46.82% | 2.27 61.19% | 0.53 76.75% | ||
working capital | -44K - | 57.60M 131,020.45% | 97.92M 69.99% | 46.81M 52.20% | 9.13M 80.50% |
All numbers in (except ratios and percentages)